SODIUM FLUORIDE

SODIUM FLUORIDE was reported 3728 times

SODIUM FLUORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VERTEBRAL LATERAL RECESS STENOSIS 6 0.3158
1 LIGAMENTUM FLAVUM HYPERTROPHY 6 0.1304
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 70 0.1048
3 OSTEOARTHROPATHY 6 0.0822
4 SERONEGATIVE ARTHRITIS 90 0.0785
5 LUPUS VULGARIS 92 0.0730
6 CHEMICAL BURN OF ORAL CAVITY 3 0.0682
7 MYOTONIC DYSTROPHY 5 0.0641
8 RESPIRATORY TRACT INFECTION BACTERIAL 26 0.0522
9 CHEMICAL BURN OF GASTROINTESTINAL TRACT 7 0.0511
10 RETINITIS 88 0.0509
11 BURN ORAL CAVITY 27 0.0469
12 DEEP VEIN THROMBOSIS POSTOPERATIVE 92 0.0459
13 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 95 0.0458
14 DISLOCATION OF VERTEBRA 99 0.0434
15 HYPOAESTHESIA EYE 17 0.0288
16 SWOLLEN JOINT COUNT INCREASED 82 0.0257
17 BONE EROSION 79 0.0223
18 GINGIVAL DISCOMFORT 14 0.0212
19 RHEUMATIC FEVER 90 0.0202
20 SWOLLEN JOINT COUNT 5 0.0200
21 CYTOMEGALOVIRUS SYNDROME 3 0.0182
22 PNEUMONITIS ASPIRATION 6 0.0175
23 GRIP STRENGTH 4 0.0175
24 EDENTULOUS 3 0.0169
25 WALKING AID USER 107 0.0162
26 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 9 0.0160
27 SPONDYLITIS 56 0.0154
28 INFECTION IN AN IMMUNOCOMPROMISED HOST 11 0.0153
29 RHEUMATOID FACTOR POSITIVE 86 0.0149
30 WOUND INFECTION 156 0.0142
31 SPINAL FUSION SURGERY 57 0.0140
32 ORAL MUCOSAL EXFOLIATION 21 0.0139
33 DUODENAL ULCER PERFORATION 90 0.0121
34 MUSCLE INJURY 98 0.0118
35 RESPIRATORY TRACT INFECTION VIRAL 27 0.0116
36 DENTURE WEARER 3 0.0116
37 TOOTH DISCOLOURATION 34 0.0115
38 BETA 2 MICROGLOBULIN INCREASED 3 0.0115
39 GINGIVAL BLISTER 5 0.0114
40 GRIP STRENGTH DECREASED 100 0.0114
41 BREAST CANCER STAGE III 72 0.0111
42 HELICOBACTER INFECTION 114 0.0111
43 DENTAL PLAQUE 3 0.0108
44 PEMPHIGUS 132 0.0105
45 HYPERCHOLESTEROLAEMIA 99 0.0102
46 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 71 0.0099
47 LUPUS-LIKE SYNDROME 89 0.0098
48 JOINT DISLOCATION 102 0.0096
49 FOLLICULITIS 99 0.0094
50 AUTOIMMUNE DISORDER 91 0.0093
51 EXOSTOSIS 84 0.0092
52 TOE OPERATION 7 0.0089
53 C-REACTIVE PROTEIN 8 0.0086
54 IMMUNOGLOBULINS INCREASED 4 0.0086
55 FOOT DEFORMITY 95 0.0086
56 FIBRIN D DIMER INCREASED 30 0.0084
57 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 53 0.0082
58 RED BLOOD CELL SEDIMENTATION RATE INCREASED 87 0.0079
59 PERICARDITIS 132 0.0078
60 HAND DEFORMITY 99 0.0075
61 SENSITIVITY OF TEETH 13 0.0075
62 PRESCRIBED UNDERDOSE 149 0.0075
63 GINGIVAL DISCOLOURATION 4 0.0074
64 JOINT RANGE OF MOTION DECREASED 99 0.0074
65 X-RAY ABNORMAL 13 0.0073
66 SCIATICA 106 0.0066
67 DRUG TOLERANCE DECREASED 18 0.0064
68 HYPERAESTHESIA TEETH 8 0.0063
69 GLOSSODYNIA 141 0.0063
70 LIP PAIN 18 0.0063
71 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 4 0.0062
72 NONINFECTIVE GINGIVITIS 9 0.0062
73 EAR INJURY 3 0.0061
74 EXOSTOSIS OF JAW 3 0.0060
75 FACET JOINT SYNDROME 19 0.0058
76 ORAL DISCOMFORT 81 0.0058
77 GINGIVAL ERYTHEMA 5 0.0058
78 OVERLAP SYNDROME 4 0.0057
79 PRESCRIBED OVERDOSE 110 0.0057
80 PORPHYRIA ACUTE 8 0.0056
81 FIBROMYALGIA 134 0.0055
82 WOUND 150 0.0054
83 BONE FRAGMENTATION 3 0.0054
84 SYNOVITIS 96 0.0053
85 HIP ARTHROPLASTY 81 0.0053
86 PULMONARY FIBROSIS 101 0.0053
87 ORAL MUCOSAL ERUPTION 8 0.0052
88 IRRITABLE BOWEL SYNDROME 110 0.0051
89 LOWER LIMB FRACTURE 98 0.0051
90 TYPE 2 DIABETES MELLITUS 167 0.0050
91 GINGIVAL DISORDER 19 0.0049
92 VERTEBRAL FORAMINAL STENOSIS 4 0.0049
93 HEPATIC CIRRHOSIS 91 0.0048
94 CIRCADIAN RHYTHM SLEEP DISORDER 4 0.0048
95 LIVER INJURY 116 0.0047
96 PERIPHERAL VENOUS DISEASE 19 0.0046
97 ORAL MUCOSAL ERYTHEMA 7 0.0045
98 ANAEMIA OF CHRONIC DISEASE 4 0.0044
99 CHEMICAL BURN 5 0.0043
100 LIVER FUNCTION TEST INCREASED 92 0.0043
101 HYPORESPONSIVE TO STIMULI 5 0.0043
102 GINGIVAL PAIN 33 0.0041
103 JOINT STIFFNESS 107 0.0041
104 TONGUE DISCOMFORT 17 0.0040
105 DISABILITY 78 0.0039
106 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 3 0.0036
107 GINGIVAL SWELLING 16 0.0036
108 CULTURE POSITIVE 3 0.0036
109 TONGUE BLISTERING 8 0.0036
110 OSTEOARTHRITIS 151 0.0036
111 EAR INFECTION 94 0.0035
112 UPPER RESPIRATORY TRACT INFECTION 161 0.0035
113 CHAPPED LIPS 15 0.0035
114 LOOSE TOOTH 11 0.0034
115 C-REACTIVE PROTEIN INCREASED 124 0.0034
116 ENTEROCUTANEOUS FISTULA 3 0.0034
117 KNEE ARTHROPLASTY 71 0.0034
118 MOUTH SWELLING 19 0.0033
119 TOOTH EROSION 4 0.0033
120 IMPAIRED HEALING 106 0.0032
121 OSTEOPOROSIS 131 0.0032
122 FISTULA DISCHARGE 4 0.0032
123 DENTAL CARIES 35 0.0032
124 GAIT INABILITY 105 0.0031
125 LIP DRY 28 0.0031
126 SYSTEMIC LUPUS ERYTHEMATOSUS 109 0.0031
127 DRUG CLEARANCE DECREASED 4 0.0031
128 DELIRIUM 106 0.0031
129 PSORIATIC ARTHROPATHY 122 0.0030
130 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 4 0.0030
131 ABSCESS ORAL 4 0.0029
132 RHONCHI 4 0.0029
133 BILIARY TRACT DISORDER 4 0.0029
134 AXILLARY MASS 3 0.0029
135 DEVICE INEFFECTIVE 3 0.0028
136 EXPOSURE VIA INGESTION 7 0.0028
137 ONYCHOMYCOSIS 12 0.0027
138 ESSENTIAL HYPERTENSION 5 0.0027
139 PRE-EXISTING CONDITION IMPROVED 17 0.0027
140 ASTIGMATISM 4 0.0026
141 LIP DISORDER 5 0.0026
142 MOUTH INJURY 4 0.0026
143 TONGUE DISORDER 19 0.0026
144 TEMPOROMANDIBULAR JOINT SYNDROME 7 0.0026
145 FAECES SOFT 19 0.0026
146 GINGIVAL RECESSION 5 0.0026
147 METHAEMOGLOBINAEMIA 6 0.0026
148 ORAL PAIN 58 0.0026
149 STOMATITIS 157 0.0026
150 CHEILITIS 14 0.0026
151 GASTROSTOMY 4 0.0026
152 SINUS PAIN 6 0.0026
153 RHINALGIA 7 0.0025
154 BLEPHAROSPASM 16 0.0025
155 TOOTH INJURY 11 0.0025
156 OEDEMA 137 0.0025
157 ALLERGIC REACTION TO EXCIPIENT 5 0.0025
158 ROAD TRAFFIC ACCIDENT 105 0.0025
159 TINEA PEDIS 4 0.0025
160 WHEEZING 148 0.0025
161 DRUG-INDUCED LIVER INJURY 78 0.0025
162 BURSITIS 30 0.0025
163 DENTAL IMPLANTATION 4 0.0024
164 CYTOKINE RELEASE SYNDROME 49 0.0024
165 TONGUE BITING 5 0.0024
166 TOOTHACHE 42 0.0023
167 ORAL DISORDER 17 0.0023
168 CRANIOCEREBRAL INJURY 7 0.0023
169 EXPOSED BONE IN JAW 5 0.0023
170 PRODUCT CONTAINER SEAL ISSUE 4 0.0023
171 BLOOD CHOLESTEROL INCREASED 107 0.0023
172 PRODUCT ADMINISTRATION INTERRUPTED 18 0.0023
173 PRODUCT FORMULATION ISSUE 15 0.0023
174 OROPHARYNGEAL DISCOMFORT 20 0.0022
175 C-REACTIVE PROTEIN ABNORMAL 14 0.0022
176 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 37 0.0022
177 OESOPHAGEAL SPASM 4 0.0022
178 ONYCHOMADESIS 9 0.0021
179 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13 0.0021
180 ESCHERICHIA BACTERAEMIA 5 0.0021
181 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 7 0.0021
182 TOOTH FRACTURE 23 0.0021
183 TONGUE ULCERATION 7 0.0021
184 COELIAC DISEASE 20 0.0020
185 INFUSION SITE REACTION 6 0.0020
186 BLOOD DISORDER 16 0.0020
187 GINGIVAL BLEEDING 27 0.0020
188 GLOSSITIS 7 0.0020
189 MASTICATION DISORDER 6 0.0020
190 BLOOD IRON DECREASED 23 0.0019
191 MOBILITY DECREASED 139 0.0019
192 DISCOMFORT 118 0.0019
193 EYE CONTUSION 4 0.0019
194 JAW FRACTURE 4 0.0019
195 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 89 0.0019
196 GAMBLING DISORDER 5 0.0018
197 PLASMA CELL MYELOMA RECURRENT 6 0.0018
198 OEDEMA MOUTH 6 0.0018
199 STOMA SITE DISCHARGE 5 0.0018
200 ARTHROPATHY 101 0.0018
201 INGUINAL HERNIA 11 0.0018
202 LIVE BIRTH 15 0.0018
203 HYPOAESTHESIA ORAL 27 0.0018
204 PROCTITIS 5 0.0018
205 INFUSION RELATED REACTION 116 0.0017
206 PUSTULAR PSORIASIS 6 0.0017
207 BLOOD CHLORIDE INCREASED 3 0.0017
208 REACTION TO EXCIPIENT 4 0.0017
209 APHTHOUS STOMATITIS 4 0.0017
210 NEPHROGENIC ANAEMIA 8 0.0017
211 SPINAL OSTEOARTHRITIS 15 0.0017
212 SPINAL STENOSIS 7 0.0017
213 INJURY 119 0.0017
214 MUSCULOSKELETAL STIFFNESS 147 0.0017
215 GINGIVITIS 9 0.0017
216 AMNESIA 106 0.0016
217 DENTAL OPERATION 4 0.0016
218 BLISTER 91 0.0016
219 NAIL DISORDER 14 0.0016
220 HEPATIC ENZYME INCREASED 109 0.0016
221 HYPERPARATHYROIDISM SECONDARY 4 0.0016
222 MELANOCYTIC NAEVUS 7 0.0016
223 EAR PAIN 31 0.0016
224 BREAST CANCER STAGE II 13 0.0016
225 MYOSITIS 14 0.0016
226 RHINOVIRUS INFECTION 6 0.0015
227 COLOSTOMY 3 0.0015
228 ORAL CANDIDIASIS 20 0.0015
229 BREAST CANCER STAGE I 14 0.0015
230 SINUSITIS 152 0.0015
231 PRODUCT TASTE ABNORMAL 20 0.0015
232 LIP BLISTER 4 0.0015
233 RESPIRATORY TRACT INFECTION 38 0.0015
234 TOOTH LOSS 29 0.0014
235 HYPERTONIC BLADDER 4 0.0014
236 BRONCHITIS 102 0.0014
237 TOOTH ABSCESS 14 0.0014
238 SPINAL DISORDER 13 0.0014
239 TONGUE DISCOLOURATION 6 0.0014
240 COLONOSCOPY 3 0.0014
241 RHINITIS ALLERGIC 6 0.0013
242 ARTHRITIS 106 0.0013
243 ULCER HAEMORRHAGE 9 0.0013
244 SWELLING 123 0.0013
245 CONTUSION 123 0.0013
246 RESPIRATORY RATE DECREASED 4 0.0013
247 PERIPHERAL SWELLING 196 0.0013
248 OBESITY 20 0.0013
249 ATELECTASIS 12 0.0012
250 BREATH ODOUR 3 0.0012
251 HYPOVENTILATION 4 0.0012
252 CONTRAINDICATED PRODUCT ADMINISTERED 37 0.0012
253 JOINT SWELLING 146 0.0012
254 IMMUNODEFICIENCY 18 0.0012
255 TACHYCARDIA 107 0.0012
256 BACK INJURY 13 0.0012
257 PATHOLOGICAL FRACTURE 6 0.0012
258 OEDEMA PERIPHERAL 144 0.0012
259 PURULENT DISCHARGE 5 0.0012
260 VISUAL IMPAIRMENT 145 0.0012
261 DYSPEPSIA 114 0.0012
262 CATHETER SITE PAIN 3 0.0012
263 SLEEP DISORDER 81 0.0011
264 PHYSICAL DISABILITY 5 0.0011
265 TOOTH EXTRACTION 14 0.0011
266 TOOTH DISORDER 25 0.0011
267 PRODUCT CONTAMINATION 4 0.0011
268 NASOPHARYNGITIS 207 0.0011
269 AGEUSIA 28 0.0011
270 DRY MOUTH 91 0.0011
271 ALCOHOL POISONING 3 0.0011
272 LIP SWELLING 37 0.0011
273 BONE LESION 4 0.0011
274 MUSCULAR WEAKNESS 126 0.0011
275 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 6 0.0011
276 URTICARIA 182 0.0011
277 GENERAL PHYSICAL HEALTH DETERIORATION 125 0.0011
278 THROAT TIGHTNESS 29 0.0011
279 BONE DENSITY ABNORMAL 4 0.0011
280 TOOTH INFECTION 14 0.0011
281 SKIN ABRASION 5 0.0011
282 CLAVICLE FRACTURE 4 0.0010
283 MOUTH ULCERATION 22 0.0010
284 ABDOMINAL DISCOMFORT 173 0.0010
285 HAEMORRHOIDAL HAEMORRHAGE 5 0.0010
286 ORAL INFECTION 4 0.0010
287 RHEUMATOID ARTHRITIS 116 0.0010
288 PNEUMONIA FUNGAL 4 0.0010
289 FOOT OPERATION 5 0.0010
290 RENAL CYST 8 0.0010
291 OESOPHAGEAL CANDIDIASIS 4 0.0010
292 HYPOAESTHESIA 150 0.0010
293 FUNGAL SKIN INFECTION 4 0.0010
294 OSTEOPENIA 15 0.0010
295 PERIPHERAL VASCULAR DISORDER 5 0.0010
296 ASTHMA 109 0.0010
297 TENDERNESS 10 0.0010
298 MEMORY IMPAIRMENT 131 0.0010
299 INFECTION 138 0.0010
300 WEIGHT INCREASED 213 0.0010
301 HYPERSENSITIVITY 174 0.0009
302 INTERVERTEBRAL DISC DISORDER 4 0.0009
303 NIGHT SWEATS 30 0.0009
304 HAEMORRHOIDS 18 0.0009
305 SOMNAMBULISM 6 0.0009
306 DEAFNESS NEUROSENSORY 3 0.0009
307 NONSPECIFIC REACTION 5 0.0009
308 HAEMORRHAGIC ANAEMIA 4 0.0009
309 PARAESTHESIA ORAL 13 0.0009
310 WHEELCHAIR USER 4 0.0009
311 SWOLLEN TONGUE 28 0.0009
312 MALNUTRITION 10 0.0009
313 PRODUCT LABEL ISSUE 6 0.0009
314 URINE ABNORMALITY 4 0.0009
315 RESPIRATION ABNORMAL 6 0.0009
316 WEIGHT FLUCTUATION 9 0.0009
317 PRODUCT LABEL CONFUSION 5 0.0009
318 ECONOMIC PROBLEM 13 0.0009
319 WEIGHT DECREASED 239 0.0009
320 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
321 SEASONAL ALLERGY 12 0.0008
322 THERMAL BURN 6 0.0008
323 DIVERTICULUM 6 0.0008
324 PSORIASIS 110 0.0008
325 TASTE DISORDER 17 0.0008
326 PROTHROMBIN TIME PROLONGED 5 0.0008
327 APHAGIA 4 0.0008
328 OSTEOMYELITIS 15 0.0008
329 SQUAMOUS CELL CARCINOMA OF SKIN 5 0.0008
330 RASH VESICULAR 4 0.0008
331 BONE DISORDER 15 0.0008
332 VITAMIN D DEFICIENCY 8 0.0008
333 CARDIAC MURMUR 7 0.0008
334 SCOLIOSIS 5 0.0008
335 IMPAIRED GASTRIC EMPTYING 11 0.0008
336 APPLICATION SITE SWELLING 4 0.0008
337 GENERAL SYMPTOM 6 0.0008
338 BACK DISORDER 13 0.0008
339 SPINAL FRACTURE 16 0.0008
340 CATHETER SITE INFECTION 3 0.0008
341 KLEBSIELLA INFECTION 4 0.0008
342 HYPERTENSION 167 0.0008
343 CONFUSIONAL STATE 127 0.0008
344 HAEMOGLOBIN ABNORMAL 5 0.0008
345 LOW DENSITY LIPOPROTEIN INCREASED 6 0.0008
346 TRISMUS 4 0.0008
347 VARICOSE VEIN 4 0.0008
348 ALOPECIA 152 0.0008
349 APHTHOUS ULCER 6 0.0008
350 HIATUS HERNIA 10 0.0008
351 FAILURE TO THRIVE 4 0.0008
352 DYSPNOEA EXERTIONAL 29 0.0008
353 CHOKING 15 0.0008
354 HYPOXIA 27 0.0008
355 TONSILLITIS 4 0.0008
356 PNEUMONIA 245 0.0008
357 PNEUMOTHORAX 12 0.0008
358 CHEST PAIN 140 0.0008
359 INTENTIONAL PRODUCT USE ISSUE 66 0.0008
360 RETCHING 16 0.0007
361 CANDIDIASIS 3 0.0007
362 FOOD POISONING 4 0.0007
363 OVERWEIGHT 4 0.0007
364 STRESS FRACTURE 4 0.0007
365 SINUS CONGESTION 10 0.0007
366 HAEMOGLOBIN DECREASED 76 0.0007
367 PRODUCT PACKAGING ISSUE 7 0.0007
368 SKIN LACERATION 8 0.0007
369 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 5 0.0007
370 SLEEP APNOEA SYNDROME 14 0.0007
371 MUSCLE SPASTICITY 9 0.0007
372 ASPIRATION 8 0.0007
373 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
374 GAIT DISTURBANCE 139 0.0007
375 SPINAL COMPRESSION FRACTURE 6 0.0007
376 HYPERKERATOSIS 4 0.0007
377 LYMPHOEDEMA 5 0.0007
378 CYSTIC FIBROSIS 4 0.0007
379 DYSPHONIA 42 0.0007
380 HEART RATE ABNORMAL 4 0.0007
381 DRUG INTOLERANCE 69 0.0007
382 SNEEZING 16 0.0007
383 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
384 BASAL CELL CARCINOMA 11 0.0007
385 DECREASED APPETITE 163 0.0007
386 DERMATITIS CONTACT 8 0.0007
387 PRODUCT CONTAINER ISSUE 6 0.0007
388 EXERCISE TOLERANCE DECREASED 4 0.0007
389 PYREXIA 240 0.0007
390 MUSCLE STRAIN 6 0.0007
391 ANXIETY 197 0.0007
392 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
393 FEEDING DISORDER 14 0.0007
394 RALES 4 0.0007
395 MUCOSAL INFLAMMATION 18 0.0007
396 HYPOVOLAEMIA 4 0.0007
397 PAIN IN EXTREMITY 201 0.0007
398 MOUTH HAEMORRHAGE 5 0.0007
399 LUNG INFILTRATION 6 0.0007
400 RESPIRATORY RATE INCREASED 6 0.0007
401 SWELLING FACE 44 0.0007
402 CHOLECYSTITIS 8 0.0007
403 ODYNOPHAGIA 4 0.0007
404 THERAPEUTIC PRODUCT EFFECT DECREASED 30 0.0007
405 FULL BLOOD COUNT ABNORMAL 7 0.0007
406 VIRAL INFECTION 22 0.0007
407 ADRENAL INSUFFICIENCY 8 0.0007
408 INCREASED TENDENCY TO BRUISE 6 0.0007
409 MENISCUS INJURY 4 0.0006
410 NERVE COMPRESSION 6 0.0006
411 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
412 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
413 HYPERCALCAEMIA 8 0.0006
414 PHARYNGITIS STREPTOCOCCAL 7 0.0006
415 OSTEONECROSIS OF JAW 16 0.0006
416 DEPRESSION 147 0.0006
417 CONCUSSION 5 0.0006
418 APHONIA 9 0.0006
419 INFUSION SITE EXTRAVASATION 4 0.0006
420 PELVIC FRACTURE 5 0.0006
421 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
422 FLANK PAIN 6 0.0006
423 SQUAMOUS CELL CARCINOMA 6 0.0006
424 CONDITION AGGRAVATED 193 0.0006
425 SCREAMING 4 0.0006
426 ATRIAL FLUTTER 5 0.0006
427 SKIN INFECTION 7 0.0006
428 OCULAR DISCOMFORT 7 0.0006
429 MITRAL VALVE INCOMPETENCE 7 0.0006
430 PHARYNGEAL SWELLING 6 0.0006
431 CHOLECYSTECTOMY 7 0.0006
432 POLYP 4 0.0006
433 METASTASES TO BONE 10 0.0006
434 ANHEDONIA 16 0.0006
435 GASTROOESOPHAGEAL REFLUX DISEASE 49 0.0006
436 NECK PAIN 34 0.0006
437 IMMUNE SYSTEM DISORDER 8 0.0006
438 CORONAVIRUS INFECTION 4 0.0006
439 PAIN IN JAW 17 0.0006
440 SKIN MASS 4 0.0006
441 HAIR TEXTURE ABNORMAL 8 0.0006
442 CHOLECYSTITIS CHRONIC 4 0.0006
443 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
444 BRONCHIECTASIS 4 0.0006
445 LYMPHADENOPATHY 21 0.0006
446 CHRONIC KIDNEY DISEASE 45 0.0006
447 DYSLIPIDAEMIA 3 0.0006
448 VITAMIN D DECREASED 5 0.0006
449 ECCHYMOSIS 4 0.0006
450 RIB FRACTURE 12 0.0006
451 CACHEXIA 3 0.0006
452 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
453 LARGE INTESTINE POLYP 4 0.0006
454 CHEST DISCOMFORT 59 0.0006
455 MIGRAINE 55 0.0006
456 HYPOMAGNESAEMIA 8 0.0006
457 LUNG DISORDER 28 0.0006
458 BURNING SENSATION 40 0.0006
459 BLOOD CALCIUM INCREASED 5 0.0006
460 BLOOD LACTIC ACID INCREASED 3 0.0006
461 DYSPHAGIA 54 0.0006
462 SPINAL OPERATION 7 0.0006
463 OROPHARYNGEAL PAIN 52 0.0006
464 COMPRESSION FRACTURE 3 0.0006
465 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0006
466 PULMONARY EMBOLISM 53 0.0006
467 THROAT IRRITATION 25 0.0006
468 DECREASED ACTIVITY 6 0.0006
469 PRODUCT COMPLAINT 14 0.0006
470 END STAGE RENAL DISEASE 10 0.0005
471 MAJOR DEPRESSION 4 0.0005
472 VOMITING 257 0.0005
473 ADVERSE DRUG REACTION 49 0.0005
474 ROTATOR CUFF SYNDROME 7 0.0005
475 RASH ERYTHEMATOUS 26 0.0005
476 RHINORRHOEA 35 0.0005
477 HYPOPHOSPHATAEMIA 4 0.0005
478 FEELING DRUNK 4 0.0005
479 PLATELET COUNT DECREASED 57 0.0005
480 BONE LOSS 8 0.0005
481 RASH 230 0.0005
482 CARDIAC VALVE DISEASE 3 0.0005
483 MUSCULOSKELETAL DISCOMFORT 9 0.0005
484 LIPASE INCREASED 4 0.0005
485 BLOOD CREATININE INCREASED 34 0.0005
486 RENAL FAILURE CHRONIC 4 0.0005
487 METASTASES TO LUNG 6 0.0005
488 THROMBOCYTOPENIA 58 0.0005
489 DIZZINESS POSTURAL 5 0.0005
490 BLOOD PRESSURE DECREASED 34 0.0005
491 THERAPY NON-RESPONDER 23 0.0005
492 BRAIN FOG 8 0.0005
493 MULTIPLE ALLERGIES 4 0.0005
494 AFFECTIVE DISORDER 4 0.0005
495 HEPATOMEGALY 5 0.0005
496 DECREASED INTEREST 3 0.0005
497 WHITE BLOOD CELL COUNT DECREASED 55 0.0005
498 DRUG SCREEN POSITIVE 4 0.0005
499 LOWER RESPIRATORY TRACT INFECTION 23 0.0005
500 HEAD INJURY 16 0.0005
501 RESPIRATORY TRACT CONGESTION 8 0.0005
502 TRICUSPID VALVE INCOMPETENCE 4 0.0005
503 ARTHRALGIA 209 0.0005
504 RESPIRATORY DISORDER 15 0.0005
505 HYPOTHYROIDISM 16 0.0005
506 SALIVARY HYPERSECRETION 5 0.0005
507 DIZZINESS 249 0.0005
508 GASTROENTERITIS VIRAL 9 0.0005
509 OBSESSIVE-COMPULSIVE DISORDER 4 0.0005
510 NOCTURIA 6 0.0005
511 ILL-DEFINED DISORDER 30 0.0005
512 MATERNAL EXPOSURE DURING PREGNANCY 44 0.0005
513 DERMATITIS ACNEIFORM 3 0.0005
514 DRY THROAT 5 0.0005
515 DECUBITUS ULCER 4 0.0005
516 EPILEPSY 15 0.0005
517 PRURITUS 188 0.0005
518 PAIN 300 0.0005
519 HYPERSOMNIA 14 0.0005
520 ESCHERICHIA INFECTION 4 0.0005
521 CONSTIPATION 106 0.0005
522 DYSGEUSIA 36 0.0005
523 TEMPERATURE INTOLERANCE 5 0.0005
524 CHOLANGITIS 3 0.0005
525 PHARYNGITIS 6 0.0005
526 BACTERIAL INFECTION 9 0.0005
527 HAIR COLOUR CHANGES 6 0.0005
528 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
529 SECOND PRIMARY MALIGNANCY 4 0.0005
530 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
531 PULMONARY HYPERTENSION 10 0.0005
532 DERMATITIS ALLERGIC 6 0.0005
533 LABORATORY TEST ABNORMAL 14 0.0005
534 CANDIDA INFECTION 8 0.0005
535 FLUID RETENTION 24 0.0005
536 COUGH 132 0.0005
537 PULMONARY MASS 7 0.0005
538 EATING DISORDER 10 0.0005
539 HYPOPHAGIA 12 0.0005
540 FATIGUE 364 0.0005
541 SKIN ULCER 12 0.0005
542 APPLICATION SITE VESICLES 3 0.0005
543 ORAL HERPES 9 0.0005
544 PRODUCTIVE COUGH 22 0.0005
545 DRY EYE 23 0.0005
546 DEAFNESS 12 0.0005
547 PULMONARY THROMBOSIS 5 0.0005
548 PHARYNGEAL OEDEMA 7 0.0005
549 HYPOKALAEMIA 21 0.0005
550 SARS-COV-2 TEST POSITIVE 6 0.0005
551 THYROID DISORDER 7 0.0005
552 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
553 LYMPHOCYTE COUNT DECREASED 8 0.0005
554 UPPER LIMB FRACTURE 9 0.0005
555 EXPIRED PRODUCT ADMINISTERED 15 0.0005
556 NERVE INJURY 5 0.0004
557 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
558 DIARRHOEA 290 0.0004
559 ACUTE MYELOID LEUKAEMIA 7 0.0004
560 BLOOD CALCIUM DECREASED 5 0.0004
561 SURGERY 26 0.0004
562 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
563 NASAL CONGESTION 26 0.0004
564 RECTAL HAEMORRHAGE 19 0.0004
565 IMPAIRED DRIVING ABILITY 5 0.0004
566 INSOMNIA 117 0.0004
567 SENSORY DISTURBANCE 7 0.0004
568 HYPOTENSION 87 0.0004
569 IRON DEFICIENCY ANAEMIA 4 0.0004
570 HUNGER 6 0.0004
571 APHASIA 13 0.0004
572 MASS 6 0.0004
573 LIVER DISORDER 19 0.0004
574 DEFORMITY 4 0.0004
575 COVID-19 75 0.0004
576 ANAPHYLACTIC SHOCK 11 0.0004
577 INFLAMMATION 22 0.0004
578 EYE PAIN 24 0.0004
579 HYPOCALCAEMIA 8 0.0004
580 SPUTUM DISCOLOURED 4 0.0004
581 BLOOD URINE PRESENT 8 0.0004
582 JOINT INJURY 9 0.0004
583 MUSCULOSKELETAL PAIN 22 0.0004
584 HYPERLIPIDAEMIA 5 0.0004
585 NAUSEA 331 0.0004
586 WRIST FRACTURE 5 0.0004
587 DERMATITIS BULLOUS 3 0.0004
588 LOCALISED INFECTION 10 0.0004
589 CRYING 15 0.0004
590 DEHYDRATION 55 0.0004
591 GASTROENTERITIS 6 0.0004
592 PLEURAL EFFUSION 25 0.0004
593 DYSPNOEA 231 0.0004
594 LIGAMENT SPRAIN 4 0.0004
595 SINUS DISORDER 8 0.0004
596 HAEMATOCRIT DECREASED 8 0.0004
597 ADVERSE EVENT 37 0.0004
598 PNEUMONIA ASPIRATION 10 0.0004
599 NEUROPATHY PERIPHERAL 38 0.0004
600 CELLULITIS 20 0.0004
601 EMPHYSEMA 4 0.0004
602 STAPHYLOCOCCAL INFECTION 13 0.0004
603 EYELID PTOSIS 4 0.0004
604 GALLBLADDER DISORDER 7 0.0004
605 BODY TEMPERATURE INCREASED 8 0.0004
606 FEBRILE NEUTROPENIA 26 0.0004
607 TINNITUS 18 0.0004
608 NEUTROPHIL COUNT INCREASED 4 0.0004
609 GOUT 7 0.0004
610 FUNGAL INFECTION 13 0.0004
611 INITIAL INSOMNIA 4 0.0004
612 EAR DISCOMFORT 4 0.0004
613 MUSCULOSKELETAL CHEST PAIN 6 0.0004
614 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
615 LEUKOCYTOSIS 7 0.0004
616 EYE DISCHARGE 4 0.0004
617 PLASMA CELL MYELOMA 15 0.0004
618 NODULE 5 0.0004
619 PRODUCT ODOUR ABNORMAL 4 0.0004
620 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
621 INCONTINENCE 4 0.0004
622 PRODUCT PRESCRIBING ERROR 9 0.0004
623 MEDICATION ERROR 21 0.0004
624 ANAEMIA 72 0.0004
625 CONJUNCTIVITIS 7 0.0004
626 HEADACHE 236 0.0004
627 ABDOMINAL PAIN 87 0.0004
628 FALL 124 0.0004
629 RASH MACULAR 13 0.0004
630 FLATULENCE 21 0.0004
631 TACHYPNOEA 5 0.0004
632 PNEUMONITIS 10 0.0004
633 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
634 ENCEPHALOPATHY 9 0.0004
635 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
636 WHITE BLOOD CELL COUNT INCREASED 14 0.0004
637 POST PROCEDURAL COMPLICATION 7 0.0004
638 ABDOMINAL PAIN UPPER 75 0.0004
639 GASTROINTESTINAL PAIN 4 0.0004
640 SPEECH DISORDER 19 0.0004
641 PARAESTHESIA 57 0.0004
642 BALANCE DISORDER 31 0.0004
643 COORDINATION ABNORMAL 5 0.0004
644 URINARY TRACT INFECTION 61 0.0004
645 CARPAL TUNNEL SYNDROME 5 0.0004
646 PANIC ATTACK 13 0.0004
647 BLOOD TEST ABNORMAL 5 0.0004
648 RESTLESSNESS 13 0.0004
649 MUSCLE SPASMS 65 0.0004
650 HEPATITIS 9 0.0004
651 SCAB 4 0.0004
652 TREATMENT FAILURE 29 0.0003
653 RED BLOOD CELL COUNT DECREASED 10 0.0003
654 IMPAIRED QUALITY OF LIFE 5 0.0003
655 BLOOD MAGNESIUM DECREASED 3 0.0003
656 EYE IRRITATION 20 0.0003
657 SEIZURE 40 0.0003
658 ORTHOSTATIC HYPOTENSION 6 0.0003
659 DYSKINESIA 14 0.0003
660 ELECTROLYTE IMBALANCE 4 0.0003
661 LOCAL SWELLING 6 0.0003
662 ANAPHYLACTIC REACTION 19 0.0003
663 SEDATION 9 0.0003
664 NEUTROPHIL COUNT DECREASED 14 0.0003
665 FEELING HOT 21 0.0003
666 SPLENOMEGALY 4 0.0003
667 PANCYTOPENIA 19 0.0003
668 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
669 CATARACT 20 0.0003
670 ACCIDENT 4 0.0003
671 GASTROINTESTINAL DISORDER 30 0.0003
672 LIMB INJURY 9 0.0003
673 ILLNESS 34 0.0003
674 DRUG DISPENSING ERROR 5 0.0003
675 BLOOD PRESSURE INCREASED 50 0.0003
676 INSURANCE ISSUE 5 0.0003
677 POOR QUALITY SLEEP 7 0.0003
678 MENTAL STATUS CHANGES 9 0.0003
679 FEELING COLD 9 0.0003
680 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
681 ANKLE FRACTURE 5 0.0003
682 TENDONITIS 5 0.0003
683 HEPATIC STEATOSIS 6 0.0003
684 EPISTAXIS 24 0.0003
685 BONE DENSITY DECREASED 10 0.0003
686 PHOTOPHOBIA 6 0.0003
687 ARTERIOSCLEROSIS 3 0.0003
688 BLOOD SODIUM DECREASED 6 0.0003
689 UNEVALUABLE EVENT 24 0.0003
690 BRAIN OEDEMA 4 0.0003
691 UNDERDOSE 23 0.0003
692 ULCER 5 0.0003
693 SEPSIS 35 0.0003
694 ABSCESS 5 0.0003
695 COLITIS ULCERATIVE 14 0.0003
696 HOSPITALISATION 48 0.0003
697 ACUTE RESPIRATORY FAILURE 6 0.0003
698 UNRESPONSIVE TO STIMULI 8 0.0003
699 HEART RATE IRREGULAR 7 0.0003
700 MUSCLE TIGHTNESS 5 0.0003
701 PRODUCT USE ISSUE 58 0.0003
702 ATRIAL FIBRILLATION 30 0.0003
703 KIDNEY INFECTION 6 0.0003
704 NEPHROLITHIASIS 14 0.0003
705 CHOLELITHIASIS 10 0.0003
706 INFLUENZA 34 0.0003
707 BODY TEMPERATURE DECREASED 3 0.0003
708 SKIN DISCOLOURATION 14 0.0003
709 DERMATITIS ATOPIC 16 0.0003
710 HYPERGLYCAEMIA 11 0.0003
711 PREGNANCY 6 0.0003
712 QUALITY OF LIFE DECREASED 4 0.0003
713 FULL BLOOD COUNT DECREASED 6 0.0003
714 PRODUCT PHYSICAL ISSUE 6 0.0003
715 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
716 BACK PAIN 69 0.0003
717 HERPES ZOSTER 17 0.0003
718 ARRHYTHMIA 14 0.0003
719 LETHARGY 17 0.0003
720 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
721 ABNORMAL DREAMS 8 0.0003
722 NERVOUS SYSTEM DISORDER 9 0.0003
723 RESPIRATORY FAILURE 21 0.0003
724 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 15 0.0003
725 NEUTROPENIA 39 0.0003
726 HAEMOPTYSIS 8 0.0003
727 DERMATITIS 6 0.0003
728 METASTASES TO LIVER 5 0.0003
729 HALLUCINATION, VISUAL 6 0.0003
730 HYPONATRAEMIA 16 0.0003
731 SKIN REACTION 4 0.0003
732 SOMNOLENCE 57 0.0003
733 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
734 HEAD DISCOMFORT 5 0.0003
735 BREAST PAIN 3 0.0003
736 BODY HEIGHT DECREASED 3 0.0003
737 HIP FRACTURE 9 0.0003
738 THIRST 5 0.0003
739 HYPOACUSIS 12 0.0003
740 HOT FLUSH 21 0.0003
741 DEEP VEIN THROMBOSIS 18 0.0003
742 HYPERTHYROIDISM 4 0.0003
743 RESTLESS LEGS SYNDROME 5 0.0003
744 DYSSTASIA 8 0.0003
745 BONE PAIN 16 0.0003
746 APPLICATION SITE PAIN 6 0.0003
747 VISUAL ACUITY REDUCED 9 0.0003
748 CARDIOMYOPATHY 4 0.0003
749 SKIN HAEMORRHAGE 4 0.0003
750 EYE SWELLING 10 0.0003
751 ABDOMINAL DISTENSION 28 0.0003
752 RASH PAPULAR 6 0.0003
753 ECZEMA 14 0.0003
754 BLOOD POTASSIUM DECREASED 8 0.0003
755 EYE INFECTION 3 0.0003
756 RENAL FAILURE 35 0.0003
757 HAEMATURIA 9 0.0003
758 FEELING JITTERY 5 0.0003
759 INCREASED APPETITE 5 0.0003
760 THROMBOSIS 21 0.0003
761 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
762 PRODUCT DOSE OMISSION 17 0.0003
763 LEUKOPENIA 13 0.0003
764 PERICARDIAL EFFUSION 6 0.0003
765 EMOTIONAL DISORDER 8 0.0003
766 FREQUENT BOWEL MOVEMENTS 7 0.0003
767 BLOOD BILIRUBIN INCREASED 7 0.0003
768 TREMOR 43 0.0003
769 LYMPHOMA 4 0.0003
770 EJECTION FRACTION DECREASED 4 0.0003
771 COGNITIVE DISORDER 12 0.0003
772 MOOD ALTERED 7 0.0003
773 FLUSHING 26 0.0003
774 SKIN LESION 7 0.0003
775 ACUTE KIDNEY INJURY 39 0.0003
776 DRY SKIN 34 0.0003
777 COVID-19 PNEUMONIA 3 0.0003
778 PRODUCT USE COMPLAINT 4 0.0003
779 RESPIRATORY DISTRESS 7 0.0003
780 ERYTHEMA 52 0.0003
781 SEPTIC SHOCK 11 0.0003
782 BACTERAEMIA 3 0.0003
783 ABNORMAL BEHAVIOUR 10 0.0003
784 BLOOD PRESSURE ABNORMAL 5 0.0003
785 CYSTITIS 8 0.0003
786 PRODUCT QUALITY ISSUE 34 0.0003
787 ASTHENIA 94 0.0002
788 DIABETES MELLITUS 19 0.0002
789 OXYGEN SATURATION DECREASED 14 0.0002
790 PRODUCT ADMINISTRATION ERROR 5 0.0002
791 NEURALGIA 6 0.0002
792 BLOOD POTASSIUM INCREASED 4 0.0002
793 PANCREATITIS 13 0.0002
794 DEPRESSED MOOD 13 0.0002
795 PRODUCT DOSE OMISSION ISSUE 72 0.0002
796 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
797 DYSURIA 9 0.0002
798 MALAISE 107 0.0002
799 CARDIOMEGALY 3 0.0002
800 PRODUCT SUBSTITUTION ISSUE 14 0.0002
801 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
802 CYST 3 0.0002
803 POLLAKIURIA 10 0.0002
804 DYSARTHRIA 9 0.0002
805 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 17 0.0002
806 HALLUCINATION 18 0.0002
807 PRODUCT USE IN UNAPPROVED INDICATION 59 0.0002
808 COLITIS 9 0.0002
809 CARDIOVASCULAR DISORDER 6 0.0002
810 IMPAIRED WORK ABILITY 5 0.0002
811 IRRITABILITY 14 0.0002
812 SKIN CANCER 5 0.0002
813 HEART RATE INCREASED 23 0.0002
814 HAEMATOMA 6 0.0002
815 PRURITUS GENERALISED 5 0.0002
816 PHARMACEUTICAL PRODUCT COMPLAINT 6 0.0002
817 MULTIPLE SCLEROSIS 11 0.0002
818 NERVOUSNESS 12 0.0002
819 SUICIDAL IDEATION 21 0.0002
820 GASTRITIS 6 0.0002
821 COMPLETED SUICIDE 19 0.0002
822 DISORIENTATION 9 0.0002
823 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
824 LIMB DISCOMFORT 7 0.0002
825 FEMUR FRACTURE 7 0.0002
826 EXPOSURE DURING PREGNANCY 14 0.0002
827 EYE HAEMORRHAGE 3 0.0002
828 THERAPY INTERRUPTED 16 0.0002
829 PALPITATIONS 26 0.0002
830 RASH PRURITIC 12 0.0002
831 PELVIC PAIN 4 0.0002
832 CORONARY ARTERY OCCLUSION 3 0.0002
833 MUSCLE TWITCHING 5 0.0002
834 SKIN EXFOLIATION 18 0.0002
835 BLINDNESS UNILATERAL 3 0.0002
836 INTESTINAL OBSTRUCTION 8 0.0002
837 FRACTURE 4 0.0002
838 FOOT FRACTURE 4 0.0002
839 INTENTIONAL DOSE OMISSION 6 0.0002
840 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
841 BRONCHOSPASM 3 0.0002
842 SYNCOPE 21 0.0002
843 SKIN DISORDER 7 0.0002
844 CONVULSION 12 0.0002
845 CARDIOGENIC SHOCK 3 0.0002
846 BLOOD GLUCOSE DECREASED 10 0.0002
847 GLAUCOMA 4 0.0002
848 MENTAL DISORDER 9 0.0002
849 EMOTIONAL DISTRESS 25 0.0002
850 CARDIAC ARREST 17 0.0002
851 PRESYNCOPE 5 0.0002
852 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 37 0.0002
853 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
854 GASTRIC DISORDER 7 0.0002
855 MENORRHAGIA 4 0.0002
856 PSYCHOTIC DISORDER 6 0.0002
857 URINARY INCONTINENCE 6 0.0002
858 NIGHTMARE 7 0.0002
859 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
860 TREATMENT NONCOMPLIANCE 11 0.0002
861 PULMONARY OEDEMA 9 0.0002
862 HYPERKALAEMIA 7 0.0002
863 LACRIMATION INCREASED 6 0.0002
864 THERAPEUTIC RESPONSE DECREASED 12 0.0002
865 BLOOD COUNT ABNORMAL 3 0.0002
866 OFF LABEL USE 173 0.0002
867 VERTIGO 12 0.0002
868 BONE MARROW FAILURE 4 0.0002
869 CHILLS 23 0.0002
870 LOSS OF CONSCIOUSNESS 25 0.0002
871 DEVICE RELATED INFECTION 3 0.0002
872 ERECTILE DYSFUNCTION 5 0.0002
873 APPLICATION SITE ERYTHEMA 5 0.0002
874 VISION BLURRED 26 0.0002
875 INJECTION SITE MASS 7 0.0002
876 MOOD SWINGS 6 0.0002
877 INTERSTITIAL LUNG DISEASE 9 0.0002
878 PAIN OF SKIN 5 0.0002
879 OSTEONECROSIS 6 0.0002
880 EYE DISORDER 6 0.0002
881 DRUG LEVEL INCREASED 3 0.0002
882 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
883 DIVERTICULITIS 5 0.0002
884 AGGRESSION 9 0.0002
885 URINARY RETENTION 6 0.0002
886 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
887 BLOOD UREA INCREASED 3 0.0002
888 PANCREATITIS ACUTE 4 0.0002
889 TOXICITY TO VARIOUS AGENTS 30 0.0002
890 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
891 INJECTION SITE REACTION 12 0.0002
892 DEVICE DEFECTIVE 3 0.0002
893 NEOPLASM PROGRESSION 6 0.0002
894 HAEMORRHAGE 18 0.0002
895 LIVER FUNCTION TEST ABNORMAL 5 0.0002
896 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
897 ACNE 13 0.0002
898 INTENTIONAL PRODUCT MISUSE 15 0.0002
899 HEART RATE DECREASED 6 0.0002
900 ASCITES 5 0.0002
901 DRUG ERUPTION 3 0.0002
902 MENTAL IMPAIRMENT 4 0.0002
903 NEOPLASM MALIGNANT 11 0.0002
904 CEREBRAL INFARCTION 4 0.0002
905 FEELING ABNORMAL 39 0.0002
906 DEVICE DISLOCATION 7 0.0002
907 ABDOMINAL PAIN LOWER 4 0.0002
908 DRUG PRESCRIBING ERROR 3 0.0002
909 MOVEMENT DISORDER 5 0.0002
910 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002
911 HYPERHIDROSIS 20 0.0002
912 RENAL IMPAIRMENT 13 0.0002
913 DIPLOPIA 4 0.0002
914 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
915 DRUG INEFFECTIVE 201 0.0002
916 COMPLICATION OF DEVICE INSERTION 3 0.0002
917 INJECTION SITE BRUISING 12 0.0002
918 AGITATION 11 0.0001
919 DISTURBANCE IN ATTENTION 8 0.0001
920 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
921 HAEMATOCHEZIA 8 0.0001
922 PROCEDURAL PAIN 4 0.0001
923 NO ADVERSE EVENT 26 0.0001
924 DEMENTIA 4 0.0001
925 TARDIVE DYSKINESIA 4 0.0001
926 RENAL FAILURE ACUTE 6 0.0001
927 MYALGIA 24 0.0001
928 CEREBRAL HAEMORRHAGE 5 0.0001
929 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
930 CARDIAC FAILURE CONGESTIVE 11 0.0001
931 MALIGNANT NEOPLASM PROGRESSION 14 0.0001
932 THERAPY CESSATION 7 0.0001
933 ANGIOEDEMA 6 0.0001
934 INJECTION SITE PRURITUS 9 0.0001
935 HEPATIC FAILURE 4 0.0001
936 SUICIDE ATTEMPT 8 0.0001
937 SKIN IRRITATION 6 0.0001
938 RENAL DISORDER 6 0.0001
939 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
940 OCULAR HYPERAEMIA 6 0.0001
941 DEATH 107 0.0001
942 CEREBROVASCULAR ACCIDENT 21 0.0001
943 EXTRA DOSE ADMINISTERED 5 0.0001
944 BLINDNESS 5 0.0001
945 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
946 WITHDRAWAL SYNDROME 5 0.0001
947 EYE PRURITUS 4 0.0001
948 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 24 0.0001
949 DISEASE PROGRESSION 14 0.0001
950 ANGER 4 0.0001
951 CARDIAC DISORDER 11 0.0001
952 BLOOD GLUCOSE INCREASED 22 0.0001
953 DEVICE ISSUE 10 0.0001
954 OVERDOSE 24 0.0001
955 INJECTION SITE PAIN 34 0.0001
956 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
957 ACCIDENTAL OVERDOSE 4 0.0001
958 DRUG ABUSE 9 0.0001
959 INCORRECT DOSE ADMINISTERED 24 0.0001
960 DISEASE RECURRENCE 5 0.0001
961 HYPOGLYCAEMIA 5 0.0001
962 DRUG DOSE OMISSION 17 0.0001
963 ABORTION SPONTANEOUS 4 0.0001
964 SKIN BURNING SENSATION 7 0.0001
965 CARDIO-RESPIRATORY ARREST 4 0.0001
966 BRADYCARDIA 5 0.0001
967 VAGINAL HAEMORRHAGE 4 0.0001
968 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
969 MYOCARDIAL INFARCTION 15 0.0001
970 INFLUENZA LIKE ILLNESS 7 0.0001
971 INJECTION SITE ERYTHEMA 10 0.0001
972 INJECTION SITE SWELLING 6 0.0001
973 INJECTION SITE HAEMORRHAGE 6 0.0001
974 DRUG EFFECT DECREASED 4 0.0001
975 DEVICE LEAKAGE 3 0.0001
976 PRODUCT STORAGE ERROR 6 0.0001
977 DRUG DEPENDENCE 11 0.0001
978 DRUG WITHDRAWAL SYNDROME 6 0.0001
979 DRUG INTERACTION 10 0.0001
980 COMA 3 0.0001
981 INTENTIONAL OVERDOSE 4 0.0001
982 CARDIAC FAILURE 5 0.0001
983 PROSTATE CANCER 5 0.0001
984 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
985 BREAST CANCER 5 0.0001
986 DRUG DOSE OMISSION BY DEVICE 4 0.0001
987 BLADDER CANCER 3 0.0001
988 DEVICE DIFFICULT TO USE 3 0.0000